Atlas Venture Life Science Advisors, LLC Q4 2025 Filing

Filed February 13, 2026

Portfolio Value

$865.2B

Holdings

8

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (8 positions)

StockValue
KYMRKymera Therapeutics, Inc.
$362.6M
DYNDyne Therapeutics, Inc.
$178.6M
SIONSionna Therapeutics, Inc.
$123.2M
IRONDisc Medicine, Inc.
$120.2M
DAWNDay One Biopharmaceuticals, Inc.
$59.8M
KRROKorro Bio, Inc.
$9.1M
QTTBQ32 Bio, Inc.
$6.9M
GBIOGeneration Bio, Co.
$4.7M